DVA DaVita Inc. Stock Quote

DVA [NYSE]

Healthcare | Medical Care Facilities | USA

Index	S&P 500	P/E	17.07	EPS (ttm)	6.39	Insider Own	0.60%	Shs Outstand	111.44M	Perf Week	3.38%
Market Cap	11.69B	Forward P/E	11.74	EPS next Y	9.28	Insider Trans	-6.48%	Shs Float	106.09M	Perf Month	1.76%
Income	783.30M	PEG	1.23	EPS next Q	1.80	Inst Own	93.40%	Short Float	2.82%	Perf Quarter	-10.81%
Sales	11.55B	P/S	1.01	EPS this Y	39.30%	Inst Trans	-6.91%	Short Ratio	3.84	Perf Half Y	25.01%
Book/sh	12.42	P/B	8.78	EPS next Y	12.56%	ROA	4.40%	Target Price	121.57	Perf Year	41.63%
Cash/sh	3.22	P/C	33.87	EPS next 5Y	13.84%	ROE	43.80%	52W Range	71.70 - 125.28	Perf YTD	-7.16%
Dividend	-	P/FCF	8.96	EPS past 5Y	38.60%	ROI	13.60%	52W High	-12.99%	Beta	1.28
Dividend %	-	Quick Ratio	1.20	Sales past 5Y	-3.50%	Gross Margin	30.80%	52W Low	52.02%	ATR	2.19
Employees	67000	Current Ratio	1.30	Sales Q/Q	0.20%	Oper. Margin	13.90%	RSI (14)	53.70	Volatility	1.71% 1.96%
Optionable	Yes	Debt/Eq	5.84	EPS Q/Q	-10.10%	Profit Margin	6.70%	Rel Volume	0.61	Prev Close	106.86
Shortable	Yes	LT Debt/Eq	5.72	Earnings	Feb 11 AMC	Payout	0.00%	Avg Volume	777.64K	Price	109.00
Recom	2.90	SMA20	0.68%	SMA50	1.12%	SMA200	10.31%	Volume	472,790	Change	2.00%

Mar-26-21

Downgrade

BofA Securities

Neutral → Underperform

$127 → $118

Jan-05-21

Downgrade

BofA Securities

Buy → Neutral

$127

Jan-24-20

Upgrade

Goldman

Neutral → Buy

$72 → $97

Nov-07-19

Downgrade

Raymond James

Outperform → Mkt Perform

Oct-25-19

Downgrade

Wolfe Research

Outperform → Peer Perform

Sep-11-19

Downgrade

William Blair

Outperform → Mkt Perform

Jul-26-19

Downgrade

Robert W. Baird

Outperform → Neutral

$70 → $65

Jan-08-19

Upgrade

UBS

Sell → Neutral

Jan-03-19

Initiated

Deutsche Bank

Buy

$60

Dec-14-18

Initiated

Barclays

Overweight

Nov-28-18

Upgrade

Raymond James

Mkt Perform → Outperform

Nov-16-18

Initiated

UBS

Sell

$64

Nov-08-18

Downgrade

Raymond James

Strong Buy → Mkt Perform

Sep-13-18

Upgrade

JP Morgan

Underweight → Neutral

Jan-04-18

Upgrade

BofA/Merrill

Neutral → Buy

Dec-12-17

Upgrade

Robert W. Baird

Neutral → Outperform

$63 → $82

Dec-11-17

Upgrade

Citigroup

Neutral → Buy

Dec-07-17

Upgrade

Raymond James

Outperform → Strong Buy

Nov-08-17

Reiterated

RBC Capital Mkts

Sector Perform

$64 → $60

Oct-09-17

Downgrade

JP Morgan

Neutral → Underweight

Mar-29-21 09:00AM	DaVita (DVA) Partners With Fresenius, Boost Home Dialysis Care Zacks
06:05AM	DaVita Shares Strategy for Achieving a Diverse Community Where Everyone Belongs PR Newswire
Mar-26-21 02:06PM	BofA Downgrades DaVita On Low Exposure to Volume Rebound Benzinga
12:45PM	6 Reasons Why Select Medical (SEM) Stock Looks Attractive Zacks
Mar-25-21 11:00AM	DaVita Statement on Government's Nationwide Program to Vaccinate Dialysis Patients PR Newswire
Mar-23-21 08:00AM	DaVita Kidney Care Expands Use of NxStage Home Hemodialysis Machines from Fresenius Medical Care PR Newswire
Mar-18-21 11:04AM	3 Warren Buffett Stocks Worth Buying Now Motley Fool
Mar-16-21 08:00AM	NephroSant Announces $16 Million Series A, Led by DaVita Venture Group ACCESSWIRE
Mar-15-21 02:32AM	I Ran A Stock Scan For Earnings Growth And DaVita (NYSE:DVA) Passed With Ease Simply Wall St.
Mar-13-21 10:30AM	DaVita HealthCare (DVA) Down 4.3% Since Last Earnings Report: Can It Rebound? Zacks
Mar-09-21 03:00AM	DaVita Inc. to Participate in the 2021 Barclays Global Healthcare Conference PR Newswire
Mar-02-21 07:00AM	RenalytixAI Reports Financial Results for Second Quarter of Fiscal Year 2021 GlobeNewswire
Feb-24-21 06:00PM	DaVita Inc. Announces Upsize and Pricing of Add-On Offering of $1 Billion Senior Notes PR Newswire
07:44AM	DaVita Inc. Announces Add-On Offering of $750 Million Senior Notes PR Newswire
Feb-23-21 06:13PM	Francis Chou's Top 4 Sells of the 4th Quarter GuruFocus.com
Feb-18-21 03:37AM	Warren Buffetts Top 10 Stock Picks Insider Monkey
Feb-13-21 01:32AM	Earnings Miss: DaVita Inc. Missed EPS By 6.2% And Analysts Are Revising Their Forecasts Simply Wall St.
Feb-12-21 11:47AM	DaVita (DVA) Q4 Earnings and Revenues Fall Shy of Estimates Zacks -7.36%
08:53AM	New Strong Sell Stocks for February 12th Zacks
Feb-11-21 09:31PM	Davita Inc (DVA) Q4 2020 Earnings Call Transcript Motley Fool
05:25PM	DaVita HealthCare (DVA) Misses Q4 Earnings and Revenue Estimates Zacks
04:47PM	Recap: DaVita Q4 Earnings Benzinga
04:06PM	DaVita Inc. 4th Quarter 2020 Results PR Newswire
03:15PM	DaVita, Inc. to Host Earnings Call ACCESSWIRE
Feb-10-21 10:36AM	DaVita's Earnings Outlook Benzinga
Feb-06-21 08:52PM	DVA Investor Alert: Kyros Law is Filing Legal Claims on Behalf of Davita Inc (NYSE:DVA) Investors PR Newswire
Feb-05-21 10:52AM	DaVita (DVA) to Report Q4 Earnings: What's in the Offing? Zacks
Jan-29-21 05:47AM	DaVita Inc. Schedules 4th Quarter 2020 Investor Conference Call PR Newswire
Jan-28-21 06:34AM	Is There An Opportunity With DaVita Inc.'s (NYSE:DVA) 30% Undervaluation? Simply Wall St.
Jan-20-21 07:47AM	3 Outpatient Home Health Stocks Set to Ride the Industry's Upturn Zacks
Jan-05-21 12:18PM	NextGen's (NXGN) Platform Gets Adopted by FPA Women's Health Zacks
09:59AM	A Look Into DaVita's Price Over Earnings Benzinga
06:00AM	Early Risk Identification at Core of Innovative Kidney Care Partnership Between Renalytix, DaVita GlobeNewswire
Jan-04-21 09:26AM	Here's Why You Should Add DaVita (DVA) to Your Portfolio Now Zacks
Dec-31-20 11:50AM	Is DaVita HealthCare (DVA) Stock Undervalued Right Now? Zacks
Dec-29-20 11:40AM	DVA vs. CHE: Which Stock Is the Better Value Option? Zacks
10:15AM	Align (ALGN) Rides on Robust Invisalign Sales Amid Coronavirus Zacks
Dec-28-20 12:18PM	Why You Must Add Merit Medical (MMSI) Stock to Your Portfolio Zacks
Dec-25-20 07:50AM	10 Best Value Stocks to Buy According to Warren Buffett Insider Monkey
Dec-23-20 01:45PM	Here's Why You Should Retain Allscripts (MDRX) Stock for Now Zacks
10:21AM	New Strong Buy Stocks for December 23rd Zacks
Dec-22-20 10:38AM	P/E Ratio Insights for DaVita Benzinga
06:07AM	DaVita Celebrates 100,000 Patients Receiving Kidney Transplants PR Newswire
Dec-21-20 08:35PM	Is DVA A Good Stock To Buy Now? Insider Monkey
11:38AM	Why You Should Retain Avanos Medical (AVNS) Stock for Now Zacks
Dec-17-20 12:56PM	Varian (VAR) Inks Deal With Yonsei Cancer Center in Korea Zacks
Dec-15-20 11:50AM	Should Value Investors Buy DaVita HealthCare (DVA) Stock? Zacks
Dec-14-20 12:46PM	Masimo (MASI) Releases Favorable Findings on Pulse Oximetry Zacks
Dec-11-20 12:55PM	The 10 Most Reliable Value Stocks to Buy for 2021 InvestorPlace
Dec-10-20 11:40AM	DVA vs. CHE: Which Stock Is the Better Value Option? Zacks
Dec-07-20 01:16AM	Is DaVita Inc.'s (NYSE:DVA) 34% ROE Better Than Average? Simply Wall St.
Nov-27-20 11:50AM	Should Value Investors Buy DaVita HealthCare (DVA) Stock? Zacks
10:54AM	Should Value Investors Choose DaVita (DVA) Stock Now? Zacks
08:30AM	Why DaVita (DVA) Could Be an Impressive Growth Stock Zacks
Nov-25-20 06:46AM	DaVita's (DVA) Shares March Higher, Can It Continue? Zacks
Nov-24-20 11:40AM	DVA or CHE: Which Is the Better Value Stock Right Now? Zacks
Nov-23-20 06:04AM	14th Annual Tour DaVita Raises Nearly $1 Million for Bridge of Life PR Newswire
Nov-20-20 09:02AM	Here's Why You Should Add DaVita (DVA) to Your Portfolio Now Zacks
Nov-19-20 07:54AM	Allscripts' (MDRX) Veradigm Collaborates With HealthVerity Zacks
Nov-17-20 08:48AM	AngioDynamics (ANGO) Shows Solid Results from RAPID Database Zacks
Nov-16-20 11:30AM	Is DaVita (DVA) Outperforming Other Medical Stocks This Year? Zacks
Nov-11-20 11:50AM	Is DaVita HealthCare (DVA) Stock Undervalued Right Now? Zacks
Nov-10-20 10:24AM	Were These Hedge Funds Wrong About Dumping DaVita Inc (DVA)? Insider Monkey
Nov-06-20 11:40AM	DVA vs. CHE: Which Stock Should Value Investors Buy Now? Zacks
Nov-05-20 11:00AM	New Strong Buy Stocks For November 5th Zacks
09:53AM	After spending millions to sway Californians votes, companies received billions in return MarketWatch
Nov-04-20 12:21PM	DaVita Rises After California Rejects Dialysis-Clinic Proposition TheStreet.com
02:13AM	DaVita Responds to Proposition 23 in California PR Newswire
Nov-03-20 01:53PM	Davita Healthcare Partners Clears Key Benchmark, Hitting 80-Plus RS Rating Investor's Business Daily
10:42AM	The Zacks Analyst Blog Highlights: United Natural Foods, The Boston Beer Company, DaVita, Owens & Minor and Primo Water Corp Zacks
10:03AM	The Zacks Analyst Blog Highlights: FedEx, Whirlpool, The Boston Beer Company, Laboratory Corporation of America and DaVita Zacks
07:14AM	6 Stocks Near 52-Week Highs Poised to Appreciate Further Zacks
Nov-02-20 08:07AM	5 Safe Stocks to Sail Through the US Election Uncertainties Zacks
07:42AM	New Strong Buy Stocks For November 2nd Zacks
Nov-01-20 09:29AM	DaVita (NYSE:DVA) Shareholders Have Enjoyed A 45% Share Price Gain Simply Wall St.
Oct-30-20 03:01PM	Davita Inc (DVA) Q3 2020 Earnings Call Transcript Motley Fool
07:07AM	DaVita (DVA) Earnings Beat Estimates in Q3, Revenues Miss Zacks
Oct-29-20 05:35PM	DaVita HealthCare (DVA) Surpasses Q3 Earnings Estimates Zacks
04:01PM	DaVita Inc. 3rd Quarter 2020 Results PR Newswire
Oct-28-20 12:26PM	Healthcare Stock Q3 Earnings Due on Oct 29: NVCR, CRL & More Zacks
10:04AM	Earnings Outlook For DaVita Benzinga
Oct-26-20 11:50AM	Are Investors Undervaluing DaVita HealthCare (DVA) Right Now? Zacks
09:45AM	DaVita (DVA) to Report Q3 Earnings: What's in the Offing? Zacks
08:49AM	New Strong Buy Stocks for October 26th Zacks
Oct-22-20 12:34PM	Analysts Estimate DaVita HealthCare (DVA) to Report a Decline in Earnings: What to Look Out for Zacks
11:30AM	Is DaVita (DVA) Stock Outpacing Its Medical Peers This Year? Zacks
09:01AM	DaVita Clinical Research to Present New Findings at American Society of Nephrology Kidney Week 2020 PR Newswire
Oct-21-20 11:40AM	DVA vs. CHE: Which Stock Should Value Investors Buy Now? Zacks
Oct-20-20 08:01AM	Baxter Supports Findings of Ongoing COVID-19 Nutrition Study Zacks
07:40AM	Here's Why You Should Invest in AmerisourceBergen (ABC) Now Zacks
07:28AM	LHC Group (LHCG) and CHRISTUS Health Extend JV Partnership Zacks
06:50AM	3 Warren Buffett Stocks Worth Buying Now Motley Fool
Oct-19-20 08:49AM	Here's Why You Should Retain AMN Healthcare (AMN) Stock Now Zacks
07:46AM	Allscripts Completes Sale of EPSi Business to Strata Zacks
Oct-15-20 04:52PM	DaVita Inc. Schedules 3rd Quarter 2020 Investor Conference Call PR Newswire
01:05PM	The Zacks Analyst Blog Highlights: Medtronic, Boston Scientific, DaVita, Accuray and Cardinal Health Zacks
12:10PM	Can DaVita HealthCare (DVA) Keep the Earnings Surprise Streak Alive? Zacks
10:15AM	COVID-19 Antigen Test Launch to Drive Abbott (ABT) Q3 Earnings Zacks
09:14AM	4 MedTech Stocks to Enrich Your Portfolio Ahead of Q3 Earnings Zacks
Oct-14-20 09:23AM	3 Best MedTech Value Stocks to Buy Ahead of Q3 Earnings Zacks

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease (ESRD). The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company provides disease management services; vascular access services; clinical research programs; physician services; and comprehensive care services. As of December 31, 2020, it provided dialysis and administrative services in the United States through a network of 2,816 outpatient dialysis centers serving approximately 204,200 patients; and operated 321 outpatient dialysis centers located in 10 countries outside of the United States serving approximately 36,700 patients. Further, the company provides acute inpatient dialysis services in approximately 900 hospitals and related laboratory services in the United States. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Arway Pamela M	Director	Mar 22	Sale	109.51	436	47,746	19,239	Mar 22 07:05 PM
DIAZ PAUL J	Director	Nov 30	Option Exercise	68.70	19,358	1,329,923	18,877	Dec 02 06:31 PM
STAFFIERI MICHAEL DAVID	Chief Operating Officer, DKC	Nov 30	Sale	109.74	25,000	2,743,515	42,431	Dec 02 06:31 PM
Arway Pamela M	Director	Nov 20	Sale	107.88	430	46,388	19,239	Nov 23 07:22 PM
STAFFIERI MICHAEL DAVID	Chief Operating Officer, DKC	Nov 18	Option Exercise	69.92	67,100	4,691,908	132,576	Nov 19 07:24 PM
STAFFIERI MICHAEL DAVID	Chief Operating Officer, DKC	Nov 17	Option Exercise	75.42	36,477	2,751,095	121,703	Nov 19 07:24 PM
DESOER BARBARA J	Director	Nov 17	Sale	111.00	1,388	154,068	430	Nov 17 09:17 PM
Arway Pamela M	Director	Nov 16	Option Exercise	68.70	19,358	1,329,923	31,292	Nov 17 09:15 PM
Arway Pamela M	Director	Nov 16	Sale	111.63	7,326	817,801	19,669	Nov 17 09:15 PM
DESOER BARBARA J	Director	Nov 11	Option Exercise	68.17	3,816	260,153	3,816	Nov 13 06:29 PM
Waters Kathleen Alyce	Chief Legal Officer	Nov 10	Sale	105.01	10,000	1,050,129	55,874	Nov 12 06:17 PM
NEHRA JOHN M	Director	Sep 23	Buy	82.95	2,500	207,374	5,500	Sep 24 06:22 PM
NEHRA JOHN M	Director	Sep 22	Buy	84.60	3,000	253,814	3,000	Sep 24 06:22 PM
ZUMWALT LEANNE M	Group VP, Government Affairs	Sep 18	Option Exercise	72.60	36,923	2,680,720	51,049	Sep 22 07:59 PM
ZUMWALT LEANNE M	Group VP, Government Affairs	Sep 18	Sale	88.03	3,772	332,031	24,590	Sep 22 07:59 PM
WESCHLER, R. TED	Member of 10% owner group	Sep 17	Sale	88.00	2,000,000	176,000,000	36,095,570	Sep 21 04:38 PM
WESCHLER, R. TED	Member of 10% owner group	Sep 17	Sale	88.00	200,000	17,600,000	1,991,806	Sep 21 04:38 PM
Arway Pamela M	Director	Aug 24	Sale	87.02	578	50,298	19,239	Aug 25 05:56 PM
BERG CHARLES	Director	Jun 08	Option Exercise	81.51	4,662	380,000	15,666	Jun 10 06:21 PM
DIAZ PAUL J	Director	Jun 08	Option Exercise	81.51	4,662	380,000	10,598	Jun 10 06:22 PM
Arway Pamela M	Director	Jun 08	Option Exercise	81.51	4,662	380,000	23,901	Jun 10 06:21 PM
ROPER WILLIAM L	Director	Jun 08	Option Exercise	81.51	4,662	380,000	20,623	Jun 10 06:21 PM
NEHRA JOHN M	Director	Jun 08	Option Exercise	81.51	4,662	380,000	4,662	Jun 10 06:22 PM
GRAUER PETER T	Director	Jun 08	Option Exercise	71.19	35,083	2,497,468	83,790	Jun 10 06:23 PM
Arway Pamela M	Director	Jun 08	Sale	87.32	357	31,174	19,239	Jun 10 06:21 PM
BERG CHARLES	Director	Jun 08	Sale	87.53	357	31,249	11,004	Jun 10 06:21 PM
ROPER WILLIAM L	Director	Jun 08	Sale	86.79	357	30,983	15,961	Jun 10 06:21 PM
Arway Pamela M	Director	May 22	Sale	78.90	599	47,261	19,239	May 27 04:05 PM
DIAZ PAUL J	Director	May 18	Sale	82.22	5,763	473,825	9,986	May 19 09:19 PM
THIRY KENT J	Executive Chairman	May 12	Sale	80.89	62,000	5,015,000	548,653	May 13 08:47 PM
THIRY KENT J	Executive Chairman	May 11	Option Exercise	75.42	145,522	10,975,269	283,369	May 13 08:47 PM
THIRY KENT J	Executive Chairman	May 11	Sale	81.28	62,000	5,039,391	610,653	May 13 08:47 PM
THIRY KENT J	Executive Chairman	May 11	Sale	81.18	5,390	437,537	137,847	May 13 08:47 PM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience